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Abstract
Background: The control of intracellular vesicle trafficking is an ideal target to weigh the role of alternative
splicing in shaping genomes to make cells. Alternative splicing has been reported for several Soluble N-
ethylmaleimide-sensitive factor Attachment protein REceptors of the vesicle (v-SNAREs) or of the target membrane
(t-SNARES), which are crucial to intracellular membrane fusion and protein and lipid traffic in Eukaryotes. However,
splicing has not yet been investigated in Longins, i.e. the most widespread v-SNAREs. Longins are essential in
Eukaryotes and prototyped by VAMP7, Sec22b and Ykt6, sharing a conserved N-terminal Longin domain which
regulates membrane fusion and subcellular targeting. Human VAMP7/TI-VAMP, encoded by gene SYBL1, is involved
in multiple cell pathways, including control of neurite outgrowth.
Results: Alternative splicing of SYBL1 by exon skipping events results in the production of a number of VAMP7
isoforms. In-frame or frameshift coding sequence modifications modulate domain architecture of VAMP7 isoforms,
which can lack whole domains or domain fragments and show variant or extra domains. Intriguingly, two main
types of VAMP7 isoforms either share the inhibitory Longin domain and lack the fusion-promoting SNARE motif, or
vice versa. Expression analysis in different tissues and cell lines, quantitative real time RT-PCR and confocal
microscopy analysis of fluorescent protein-tagged isoforms demonstrate that VAMP7 variants have different tissue
specificities and subcellular localizations. Moreover, design and use of isoform-specific antibodies provided
preliminary evidence for the existence of splice variants at the protein level.
Conclusions: Previous evidence on VAMP7 suggests inhibitory functions for the Longin domain and fusion/growth
promoting activity for the Δ-longin molecule. Thus, non-SNARE isoforms with Longin domain and non-longin
SNARE isoforms might have somehow opposite regulatory functions. When considering splice variants as “natural
mutants”, evidence on modulation of subcellular localization by variation in domain combination can shed further
light on targeting determinants. Although further work will be needed to characterize identified variants, our data
might open the route to unravel novel molecular partners and mechanisms, accounting for the multiplicity of
functions carried out by the different members of the Longin proteins family.
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The human gene SYBL1 (synaptobrevin-like 1) expres-
sion is finely regulated at different layers. Even if located
in the Xq/Yq pseudoautosomal region, SYBL1 is subject
to છ inactivation [1] and its allelic expression is con-
trolled by multiple epigenetic mechanisms [2]. More-
over, SYBL1 expression is altered in human pathologies
characterized by DNA methylation derangement [3],
such as ICF syndrome [4,5] and hyperhomocysteinemia
[6]. SYBL1 encodes the v-SNARE protein VAMP7, an
important modulator of intracellular trafficking also
known as Tetanus neurotoxin Insensitive VAMP (TI-
VAMP) [7]. Soluble N-ethylmaleimide-sensitive factor
attachment protein receptors (SNAREs) of the vesicle
(v-SNAREs) and the target membrane (t-SNARES) are
crucial to intracellular membrane fusion and protein
and lipid traffic in Eukaryotes [8]. Since the hydrophobic
heptad register of their a-helical coiled-coil region
(SNARE motif) is interrupted at the so-called “zero
layer” by a conserved R or Q residue, they are often
referred to as R- or Q-SNAREs, respectively [9].
SNAREs can significantly vary in sequence length (e.g.
from <100 amino acids of some synaptobrevins to
>1100 residues among tomosyns) because of their mod-
ular domain architecture. In addition to SNARE motifs
they can show further regions, such a carboxy (C)-term-
inal transmembrane region, motifs allowing post-transla-
tional addition of lipid anchors [8] and a variable or
conserved amino (N)-terminal domain. The N-terminal
Longin domain (LD) of longins [10] was found to play
multiple regulatory roles (reviewed in [11]). Longins are
the only R-SNAREs conserved in all Eukaryotes, whereas
brevins are limited to bilateria and hence are absent
from whole taxa (e.g., plants) [12]. Longins group into
three subfamilies, prototyped by Ykt6, Sec22b and
VAMP7 [11]. In yeast, the LD of Ykt6p can regulate
membrane fusion by inhibiting Ykt6p participation to
the fusion bundle, by competitive intramolecular binding
to the SNARE motif [13]. The LD of VAMP7 also regu-
lates membrane fusion; furthermore, it is crucial to
neurite outgrowth, as overexpression of a “deregulated”
fragment missing the LD (Δ-longin) increases neurite
outgrowth whereas reverse effect (outgrowth inhibition)
is obtained when expressing the LD alone [14,15]. In
addition to regulating membrane fusion, LDs serve as a
dominant signal for subcellular targeting. For example,
in animals LD targets VAMP7 to late endosomes by
binding to the δ-subunit of the AP-3 complex [16]. In
plants, several VAMP7 proteins are targeted to their dif-
ferent subcellular localizations by their LDs [17]. The
LD targets Ykt6 to its subcellular localization, likely by
masking other localization signals [18]. In Sec22b,
export from the endoplasmic reticulum is mediated by
binding to Sec23/24, a process depending on a confor-
mational epitope created by intramolecular LD-SNARE
motif binding; such binding also results in preventing
promiscuous, unspecific binding by sequestering the N-
terminal half of the SNARE motif [19]. Also VAMP7
adopts a closed conformation based on intramolecular
LD-SNARE motif binding [20]. Hrb, a clathrin adaptor
and ArfGAP, binds the LD of VAMP7 by its unstruc-
tured SNARE-like motif, outcompeting the SNARE
motif of VAMP7 for the same groove and suggesting
that Hrb-mediated endocytosis of VAMP7 occurs only
when this longin is incorporated into a cis-SNARE com-
plex [21,22]. VAMP7 has been found to also interact
with the positive regulator of neurite growth Varp, a
guanine nucleotide exchange factor (GEF) of the small
GTPase Rab21 and a binding partner of Rab 32 and Rab
38 [23,24].
Like other highly regulated processes typical of eukar-
yotic cells, subcellular trafficking needs fine tuning of
protein functions and structures. Modulation of domain
architecture and creation or deletion of sequence motifs
can in turn be achieved by alternative splicing (AS): this
way, a relatively large proteome can be created starting
from a limited number of genes [25]. Indeed, AS has
been shown to occur in several trafficking-related genes,
including SNARE genes, resulting in the production of
isoforms with different subcellular localization and traf-
ficking properties. Developmentally regulated AS of
SNAP-23 and SNAP-25 modulates interactions with
accessory factors and subcellular localization [26,27]; AS
also regulates interaction properties in the large t-
SNARE family of syntaxins, by varying their N-terminal
and/or C-terminal regions [28]. In R-SNAREs, AS can
finely tune vesicle subcellular targeting by varying the
extreme C-terminal region in splice variants of VAMP1
[29,30], and tissue-specific AS of mammalian tomosyn is
involved in the regulation of neuronal secretion [31,32].
In most Eukaryotes, the involvement of VAMP7 in mul-
tiple trafficking events at different subcellular compart-
ments is mediated by gene amplification and variation
[33]. In mammals, VAMP7 is encoded by a single gene
and yet it regulates multiple subcellular pathways
[33,34]: hence, AS is a likely strategy to achieve such
complexity in regulation. Thus, we have started investi-
gation on longins (the most conserved R-SNAREs) by a
thorough analysis for the occurrence of AS at the
human gene SYBL1.
Results and discussion
Exon skipping at the SYBL1 locus results in modulating
isoform domain architecture
Human gene SYBL1 is composed of eight exons, span-
ning a genomic region of approximately 35 kb [35].
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Page 2 of 13Figure 1 shows that its genomic structure is intriguingly
related to the domain architecture of VAMP7 (Uni-
ProtKB/Swiss-Prot accession P51809): the LD is
encoded by exons 2 to 4, whereas exons 5 to 8 encode
the helical domains (SNARE motif and transmembrane
region). Within the literature two AS variants of
VAMP7 have been described, the main isoform
VAMP7a (P51809-1) and a variant, VAMP7c, missing
part of exon 2 and exon 3 (P51809-3). We identified
isoform VAMP7b, missing exon 6, during the screening
of a cDNA library [1]. We deposited the RNA and pro-
tein sequences into database (accession numbers being
respectively AJ295938 and P51809-2) and the characteri-
zation is reported in this work. Database searches
allowed us to identify EST clone AW163735, likely cor-
responding to an uncharacterized splice variant missing
exon 3, hereafter called VAMP7d. We then performed
RT-PCR to unravel AS at the SYBL1 locus. Preliminary
experiments with primers pairing to the untranslated
regions of the gene amplified multiple fragments (not
shown), the longest of which corresponding to
VAMP7a; we found no intron retention, suggesting AS
of SYBL1 is based on exon skipping. This prompted us
to set up more specific and resolutive experiments,
investigating 5’ and 3’ SYBL1 splicing events separately.
Exon skipping at the 5’ half of the gene results in
synaptobrevin-like, “non-longin” isoforms
W ef i r s te x a m i n e dA Sa tt h e5 ’ end of the SYBL1 locus
and identified three isoforms, “c”, “d” and “h”, that would
disrupt production of the Longin domain (Figure 2A). AS
at LD-codifying exons was firstly screened with the for-
ward primer including the canonical ATG codon of the
SYBL1 gene. Three bands smaller than isoform “a” were
sequenced, of which one confirmed the bioinformatically
captured isoform “d” missing exon 3. The two other bands
resulted from the use of a cryptic GT donor splice site
inside exon 2 joined to the AG acceptor splice site of
either exon 3 (isoform “h”)o re x o n4( i s o f o r m“c”). In
order to characterize the 3’ architecture of each isoform,
we used an “allele specific oligonucleotide” PCR (ASO-
PCR) approach [36]. ASO-c, ASO-d and ASO-h forward
primers anneal specifically only to c- or d- or h-like
isoforms (showing incomplete LD sequences), completely
abolishing any other splice-molecule influence. Each of
these ASO primers was combined to a common reverse
primer specific to SYBL1-exon 8, performing four different
sets of RT-PCR with cDNAs from different tissues and cell
lines (Figure 2). We could conclude that “non-longin” iso-
forms - i.e. splice variants missing the LD - retain all the
canonical exons from 4 to 8 (not shown), but with differ-
ent consequences on the reading frame. VAMP7c was
already described: the splicing event skips out 40 residues
of the N-terminal region (which thus cannot fold as a LD),
but the mRNA retains the original reading frame, leading
to the correct translation of the “synaptobrevin-like” part
of the sequence (including SNARE motif, transmembrane
region and intravesicular tail) [16]. Translation of both
V A M P 7 da n dV A M P 7 hm R N A sw o u l dr e s u l ti ns h o r t
peptides (59 and 45 aa, respectively) when starting from
the canonical translation initiation start (TIS) of SYBL1,
which is located in exon 2. However, scanning of the
SYBL1 sequence (using StartScan [37]) identified a second,
alternative TIS in exon 5, showing “optimal status” with
respect to sequence context and distance from the
upstream stop codons to reinitiate translation (Figure 2B).
Such translation reinitiation mechanism is well-known in
Homo sapiens a n di ta l l o w sf o rp r o d u c i n ga l t e r n a t i v e ,
functional proteins from mRNAs which would otherwise
originate only short peptides when using only the canoni-
cal TIS [38-42]. Since the alternative TIS in exon 5 is com-
mon to “d” and “h” isoforms, both mRNAs are likely to
produce by translation reinitiation the same polypeptide,
hence named “VAMP7d/h”. Intriguingly, VAMP7d/h, cor-
responding to last 94 residues of VAMP7a, lacks the LD
and consists only of the SNARE motif, transmembrane
region and intravesicular tail, possibly representing a phy-
siological equivalent of the “Δ-longin” recombinant
VAMP7 construct enhancing membrane fusion and neur-
ite outgrowth when expressed in neurons [15].
Skipping of SYBL1 exons 5 and/or 6 produces non-
SNARE, LD protein isoforms
Examining the 3’ end of the gene we identified three
splice variants, “b”, “i” and “j” that result in proteins con-
taining the LD but not the SNARE motif (Figure 2C).
1 1 2 2 3 3 4 4 5 5 7 7 8 8
SYBL1 SYBL1
6 6
VAMP7 VAMP7
Figure 1 Genomic structure of SYBL1 and domain architecture of VAMP7. Top: exon-intron structure of the human gene SYBL1 (AJ004799).
The 100 bp reference bar (blue, top left) only refers to exons; introns are not to scale. Exons are numbered: coding regions are white and non-
coding ones are grey; start (green arrow) and stop (red circle) codons are indicated. Bottom: domain architecture of the encoded protein VAMP7
(P51809): Longin domain (red), SNARE motif (cyan; the black vertical bar indicates the conserved arginine of the polar layer) and transmembrane
region (light green) with intravesicular tail (thin light green line).
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Figure 2 RT-PCR analysis of alternative splicing of SYBL1. Sizes (in base pairs) of MW markers and expected lengths of amplified fragments
are reported. Isoforms and corresponding amplified fragments are color coded. Exonic structure of VAMP7a has grey background. The
photographs show RT-PCR amplifications using cDNAs from tissues (1-19) or cell lines (20-27): 1, fetal brain; 2, total brain; 3, hippocampus; 4,
cerebellum; 5, fetal heart; 6, heart; 7, skeletal muscle; 8, fetal liver; 9, liver; 10, mammary gland; 11, testis; 12, ovary: 13, pancreas; 14, kidney; 15,
spleen; 16, colon; 17, small intestine; 18, stomach; 19, placenta; 20, T lymphocytes; 21, Raji; 22, HeLa; 23, RPE; 24, U937; 25, HEK293; 26, ND2; 27,
ND2 15 days after induction. Panel A: variants missing the LD (VAMP7c, red; VAMP7d, orange; VAMP7h, yellow) were identified using SYN1F/R
primers, placed on exon 2-containing ATG and exon 4. Panel B: structures of the VAMP7d and VAMP7h mRNAs and analysis of translation
initiation sites (TIS). The nucleotide context for each TIS is aligned to the mammalian consensus (R, purine = A/G); nucleotides crucial to optimal
initiation are green. Arrows indicate optimal (green) and non-optimal (black) TIS; red circles are stop codons. SNARE motif (cyan), conserved
arginine (black vertical bar) and transmembrane region with intravesicular tail (light green) are also reported. Panel C: non-SNARE variants
(VAMP7b, dark blue; VAMP7i, blue; VAMP7j, light blue) were identified by semi-nested RT-PCR with a VAMP7a specific ASOa primer (SYB2/3F)
combined to a 3’UTR primer (Tel3) then to a nested primer (TBP5).
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respectively: (i) exon 6 (VAMP7b), (ii) exon 5 (VAMP7i)
and (iii) both exons (VAMP7j) - show different domain
architectures possibly underlying different cellular roles.
VAMP7b is 40 amino acids longer than VAMP7a and it
shares with the main isoform the LD and N-terminal
part of the SNARE motif. Then, a frameshift downstream
of exon 5 results in substitution of both the C-terminal
half of the SNARE motif and the transmembrane region
by a novel C-terminal region of 116 amino acids. On the
other hand, VAMP7i basically consists of the LD alone:
exons 1 to 4 encode for the first 114 residues of VAMP7,
including all secondary structure elements needed to
achieve a complete LD fold (according to PDB structure
2dmw). Skipping of exon 5 then results in a frameshift
that leads to the translation of just two additional resi-
dues, followed by a premature stop codon. As for
VAMP7j, it is a kind of “membrane-anchored version” of
VAMP7i: skipping of both exons 5 and 6 preserves the
original frame in which the LD is followed by a short
hinge region preceding the original transmembrane and
intravesicular tail regions, shared with the main isoform.
Multiple skipping of exons 3 to 6 was found to result in a
number of putative additional isoforms; however, multi-
exon skipping often derives from splicing errors instead
of programmed AS and “false” isoforms can be recog-
nized by quite low expression levels [43]. Therefore, we
performed semi-quantitative and quantitative RT-PCR
screens and expression levels of these putative isoforms
were found to be less than 0.1% (not shown) of the main
isoform, as reported for splicing errors [43]. Even though
the existence of further isoforms cannot be excluded,
assays performed so far show that AS at the SYBL1 locus
results in the production of seven isoforms with varying
domain architecture (Figure 3).
Quantitative expression and tissue specific distribution of
VAMP7/TI-VAMP isoforms
Real-time RT-PCR was performed on a panel of human
cell lines and tissues, in order to obtain amplicons speci-
fic to VAMP7 isoforms (see methods). Figure 4 sum-
marizes quantitative expression data. The upper graph
illustrates relative contributions to the mRNA pool from
VAMP7a (grey) and alternative splice variants (black).
VAMP7a contribution to the mRNA pool amounts to
60-70% in cell lines (samples 1-5) and 40-60% in tissues
(samples 6-10); in three out of five tissues, the sum of
alternative variants (b, c, d, h, i, j) overpass 50% of the
VAMP7 mRNA. The central graph illustrates the
mRNA levels of single isoforms; splice variants range 5-
12% of VAMP7a in cell lines, while their levels are
much higher in tissues. For instance, in colon (sample
8) the aggregate level of VAMP7i+j mRNAs is compar-
able to VAMP7a and in skeletal muscle (sample 9)
VAMP7i alone is comparable to the main isoform. In
pie charts, 100% refers to the mRNA pool of alternative
v a r i a n t s ,e x c l u d i n gV A M P 7 a .P r e p o n d e r a n c eo fL D
+,
non-SNARE isoforms ("b”, “i” and “j”) is apparent in cell
lines and it becomes more evident in tissues, where
their aggregate level is comparable or even higher than
that of VAMP7a. In particular, the non-SNARE/SNARE
isoform ratio can shift from approximately 1:1 in cell
lines to up 3:1 in tissues. In most tissues and cell lines,
the second most expressed isoform (after VAMP7a) is
VAMP7j, which is highly expressed in colon. The level
of alternative variants in neuroblastoma cells (sample 5)
and fetal brain (sample 6) is lower than that found in
adult brain (sample 7), where the expression of
VAMP7a is high (in agreement with literature [1]).
Immunodetection of isoforms by domain-specific
oligoclonal antibodies
In order to get evidence on isoforms at protein level, oli-
goclonal antibodies were made to regions of VAMP7:
MD2 recognizes just the LD, MD3 the C-terminal half of
the SNARE motif, MD4 and MD5 the alternative non-
SNARE C-terminal region of VAMP7b (see Figure 5 for
domain and isoform recognition specificity). Specificity
of each antibody was checked (see methods) and con-
firmed by complete absence of non specific recognition,
even at high concentration (1:100); MD4 and MD5
yielded a stronger signal than MD2 and MD3. For immu-
noblotting experiments, two identical series of protein
samples were separated by SDS-PAGE, blotted and incu-
bated with antibodies specific to the LD and SNARE
motif of VAMP7 (MD2 and MD3, which were used in
combination, as oligoclonal antibodies are weaker than
polyclonal ones) or to the unique C-terminal region of
VAMP7b (MD4 and MD5). In extracts from bacteria
expressing VAMP7 fragments, MD2+MD3 recognized
bands of the expected MR of GST-cytoplasmic domain of
VAMP7a (sample 2) and of thioredoxin-LD (sample 4);
MD4+MD5 recognized only the band corresponding to
thioredoxin-C-terminal region of VAMP7b (sample 5).
Specificity was confirmed by the fact that no band could
be seen in control extracts from bacteria expressing the
empty plasmids (samples 1 and 3). Specificity of MD4
+MD5 antibodies was expected to be high also when
using human cell extracts, because exhaustive scanning
of the human genome failed to find sequences with sig-
nificant similarity to the C-terminal region of VAMP7b.
Such prediction was confirmed by the fact that among
endogenous human proteins (lane 6, right blot), MD4
+MD5 recognized a single band of approximately 30 kDa
(expected MR of VAMP7b). As expected, MD2+MD3
identified a main band of approximately 25 kDa (MR of
VAMP7a) and the 30 kDa band corresponding to
VAMP7b (lane 6, left blot). Recognition of VAMP7b by
Vacca et al. BMC Molecular Biology 2011, 12:26
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Page 5 of 13both antibody panels is in agreement with MD2 specifi-
city to the LD, shared by isoforms “a” and “b”. Intensities
of the two 30 kDa bands are also in agreement with rela-
tive strengths of the antibodies (MD4+MD5 >> MD2
+MD3). Moreover, relative intensities of the 25 kDa and
30 kDa bands in lane 6 (left blot) are in agreement with
higher expression of the main isoform (as reported in
Figure 4). Given that MD2+MD3 are expected to weakly
recognize all splice variants reported here, additional
bands in lane 6 (left blot) are likely to correspond to
other isoforms. In particular, the two bands in between
25 kDa and 15 kDa markers are compatible with
expected MR of VAMP7c (~20 kDa) and VAMP7j (~19
kDa) and the band slightly over the 10 kDa marker might
correspond to VAMP7d/h (~10.5 kDa). To better identify
the minor bands, the same sample (extract from Jurkat
cell) was investigated using MD2 and MD3 antibodies
separately (lanes 6 in betwee nt h et w ol a r g eb l o t s ) .A s
expected, MD2 (specific to the LD) recognized - in
addition to VAMP7a (25 kDa) and VAMP7b (30 kDa)
bands - the 19 kDa band likely corresponding to
VAMP7j. MD2 did not recognize the bands of ~20 and
10-11 kDa, suggesting that corresponding proteins lacked
the LD epitope. This was confirmed by the somewhat
“reverse” pattern seen when using the SNARE-specific
antibody alone: in addition to VAMP7a, MD3 recognized
the bands of ~20 kDa (expected MR of VAMP7c) and 10-
11 kDa (expected MR of VAMP7d/h), while it did not
recognize those putatively corresponding to isoforms
VAMP7b and VAMP7j, both of which are missing the
SNARE epitope. Absence of a band for VAMP7i is not
surprising, given that this isoform shows low expression
in Jurkat cells and it would be recognized only by the
weakest antibody (MD2). Quantitative PCR data showed
that in human tissues the expression of minor isoforms is
relatively high. However, the MD antibodies could not be
used with tissue extracts from other mammals, because
AS at the SYBL1 locus shows organism-specific
1 1 2 2’ ’ 4 4 5 5 7 7 d d 2 2’ ’’ ’ 6 6 8 8
1 1 4 4 5 5 7 7 c c 6 6 2’ 8 8
1 1 2 2’ ’ 3 3 4 4 5 5 7 7 8 8
a a
2 2’’ ’’ 6 6
1 1 2 2’ ’ 3 3 4 4 j j 2 2’’ ’’ 7 7 8 8
1 1 2 2’ ’ 3 3 4 4 8 8 7 7 i i 2 2’’ ’’ 6 6
1 1 2 2’ ’ 3 3 4 4 5 5 7 7 b b 2 2’’ ’’ 8 8
h h 1 1 3 3 4 4 5 5 6 6 2’ 7 7 8 8
main isoform main isoform
non-SNARE variants non-SNARE variants
non-longin variants non-longin variants
Figure 3 Alternative mRNAs of the human SYBL1 gene and corresponding VAMP7 isoforms. Coding exons or their fragments are white;
non coding ones are grey. Introns are not to scale. Domain architecture: Longin domain, red; SNARE motif, cyan (the conserved arginine of the
polar layer is indicated by a vertical bar); transmembrane region and intravesicular tail, light green; N-terminal region of VAMP7c, grey; unknown
function region of VAMP7b, magenta.
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Page 6 of 13regulation, as e.g splice variants in human and mouse are
different in both number and structure (M. Vacca,
unpublished results). Therefore, further investigations
will be needed to confirm the presence of all isoforms at
protein level.
VAMP7/TI-VAMP isoforms show different subcellular
localizations
The only VAMP7 splice variant characterized so far is
VAMP7c: its truncated N-terminal region is unable to
bind δ-AP3 and this results in a subcellular localization
0
20
40
60
80
100
123456789 1 0
0.0
0.2
0.4
0.6
0.8
1.0
2.6
2.8
123456789 1 0
2 4 5 3 1
9 10 6 7 8
a
b
i
d
h
j
c
Figure 4 Quantitative analysis of the VAMP7 isoform mRNA levels in human cell lines and tissues. Color coding for all isoforms is
reported; in the upper graph, 100% is the VAMP7 mRNA pool, of which the black part represents the pool of alternative isoforms (b+c+d+h+i+j)
mRNA. In the middle, original data (mRNA levels of each isoform) are reported as % of the housekeeping reference gene (ribosomal S13) mRNA.
Lower graphs compare individual levels within the pool of alternative isoforms (excluding VAMP7a). Cell lines (1-5) and tissues (6-10) are the
followings: 1, C63; 2, HepG2; 3, HeLa; 4, Jurkat; 5, SH-SY5Y; 6, fetal brain; 7, adult brain; 8, colon; 9, skeletal muscle; 10, spleen.
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Page 7 of 13that differs from that of the main isoform [16]. Since the
newly identified isoforms (b, d/h, i, and j) also show var-
iant domain architectures, we compared their subcellular
localization to the main isoform using fluorescent protein
tagged chimeras. Figure 6 shows confocal plane images
from living HeLa cells that were co-transfected with
EGFP-tagged splice variant and RFP tagged main isoform.
Large yellow areas of co-localization are apparent in
merged images for VAMP7d/h. On the other hand,
VAMP7b shows a somewhat widespread distribution and
the subcellular localization of VAMP7j is also different
from the punctate localization of VAMP7a, as red areas
are clearly apparent in merged images. However, partial
co-localization with VAMP7a cannot be excluded. Intrigu-
ingly, VAMP7i is the only isoform that also shows a
nuclear localization. However, highly widespread VAMP7i
and punctate, restricted-area VAMP7a indicate a quite dif-
ferent subcellular localization also in the cytoplasm.
MD2 MD3
MD4 MD5
Figure 5 Immunoblotting with domain-specific anti-peptide antibodies. Each MD antibody shares the color with the recognized domains:
MD2, Longin domain, red; MD3, SNARE motif, cyan; MD4 and MD5, unknown function region of VAMP7b, magenta. Other represented regions
are the N-terminal region of VAMP7c (grey) and the transmembrane region with intravesicular tail (light green). The two large blots share the
same series of whole lysates from E. coli cells (lanes 1-5) or Jurkat cells (lane 6) and each blot was incubated with antibodies indicated on the
top. Bacterial cells express empty control plasmids (lane 1, pGEX; lane 3, pET32H), or the following VAMP7 fragments: cytoplasmic of VAMP7a
fused C-terminally to GST in pGEX (lane 2), LD of VAMP7a fused C-terminally to thioredoxin in pET32H (lane 4), C-ter region of VAMP7b fused C-
terminally to thioredoxin in pET32H (lane 5). Molecular weight markers are reported.
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Fine tuning of gene functions is an important strategy
by which higher organisms can achieve their complexity
without needing a proportional increase in gene num-
ber. Indeed, AS at a single locus can result in the pro-
duction of a (small to large) number of splice isoforms
with varying domain architecture and function(s). It is
noteworthy that increased complexity in trafficking
routes mediated by VAMP7 is achieved in plants by
increased gene number, whereas a corresponding
increase in animals is not apparent. Rather, as observed
for other SNAREs and trafficking proteins, the SYBL1
locus undergoes AS and this in turn results in a number
of VAMP7 isoforms with intriguing modulation in
domain architecture. Further work will be needed to
characterize biochemical, structural and cellular proper-
ties of each isoform. However, these “natural mutants”
of VAMP7 can be now used to shed more light on the
VAMP7b
VAMP7d/h
VAMP7j
VAMP7i
VAMP7a
VAMP7a
VAMP7a
VAMP7a
Figure 6 Variation of subcellular targeting among VAMP7 isoforms. Living HeLa cells, co-expressing an EGFP tagged splice variant of
VAMP7 (left column) and the RFP tagged VAMP7a (central column). Merged images are presented on the right column. Reference white bars
correspond to 5 μm. Confocal planes are presented.
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Page 9 of 13function(s) of the LD and other regions/domains. To
this aim, artificial constructs have been used so far: the
subcellular localization of several chimeric VAMP7 pro-
teins was compared in plants [17], whereas separated
VAMP7 domains were used to investigate both subcel-
lular localization and effects on mammalian cell physiol-
ogy. In particular, a synaptobrevin-like Δ-longin
fragment and an LD-only constructs were found to elicit
somewhat opposite effects [14,15]. Isoforms VAMP7d/h
and VAMP7i show the same domain architectures of
respectively Δ-longin and LD-only fragments and are
likely to mediate equal/similar effects. Noteworthy,
VAMP7d/h and Δ-longin fragment co-localize with
VAMP7a, while VAMP7i and LD-only do not, thus
showing congruent subcellular sorting in two different
cell types (neuronal and epithelial). AS at the SYBL1
locus results in a more sophisticated modulation of the
domain architecture: two non-SNARE isoforms consist
of the LD alone (VAMP7i) or “membrane-anchored” LD
(VAMP7j), and two Δ-longin isoforms (VAMP7d/h, this
work and VAMP7c, [16]) share synaptobrevin-like archi-
tecture with different N-terminal extensions. Finally,
VAMP7b is only partially “non-SNARE” because it still
keeps the N-terminal part of the SNARE, which is cru-
cial for intramolecular binding to the LD, closed confor-
mation and targeting [19]. VAMP7b and VAMP7a show
different subcellular localization, in agreement with evi-
dence that other protein regions/domains can modulate
subcellular targeting capacity of the LD [21,22]. This is
further suggested when comparing VAMP7i and
VAMP7j, which share the LD and lack the SNARE
motif. VAMP7i is found in the nucleus, whereas the
transmembrane anchor in VAMP7j is likely to prevent
nuclear localization. Indeed, VAMP7i consists only of
the LD fold, similar to longin-like proteins [11] like s
AP [44] and sedlin [45]. Intriguingly, sedlin has been
recently reported to show nuclear localization and to
interact with transcription factors (TF) and TF-binding
proteins [46,47]. Production by AS of non-SNARE iso-
forms further strengthens the concept that the LD can
play an important role in trafficking independently on
the SNARE motif, as suggested by the existence of non
SNARE longins [33]. Tissue-specific expression data
suggest that AS at the SYBL1 locus is developmentally
regulated along cell lineage/tissue differentiation. Alter-
native mRNAs encoding variants with different domain
combinations are expressed at levels ranging 5-12% of
VAMP7a (Figure 4) in cell lines. In differentiated tissues
the aggregate level of non-SNARE, inhibitory variants is
comparable or even higher than VAMP7a. Each isoform
m i g h tc o n t r i b u t et of i n e l yt u n eV A M P 7 - m e d i a t e dr e g u -
lation of cell physiology: indeed, several regulatory
mechanisms do not require for 1:1 interactions. The
main isoform is distributed among multiple locations
along its trafficking route, because of interactions
mediated by all its domains. Instead, splice variants
missing either the LD or the SNARE motif are likely
more involved in specific interactions, thus increasing
their relative weight in influencing specific trafficking
events. Evidence from this work further suggests that
AS may contribute to finely tune the vesicle-mediated
membrane trafficking specificity, providing new insights
about the biological importance of the Longin domain
over the SNARE functions.
Methods
Cell culture
The following human cell lines were used in this work:
SH-SY5Y (neuroblastoma); C63 (skin fibroblasts);
HepG2 (hepatocellular carcinoma); HeLa (cervical carci-
noma); Jurkat (T-cell leukaemia). All cells were grown
at 37°C in a humidified atmosphere, 5% CO2.S H - S Y 5 Y
and Jurkat cells were grown in the following media (all
reagents from Invitrogen), supplemented with Glutamax
and 10% heat-inactivated fetal bovine serum: SH-SY5Y,
1:1 DMEM+Ham’s F12 supplemented with gentamicin
(50 μg/ml); Jurkat, RPMI supplemented with 10 mM
HEPES and PEN-STREP. C63, HepG2 and HeLa cells
were kindly provided by colleagues from other
laboratories.
RNA extraction and retrotranscription
Total RNA from cell cultures was extracted using TRI-
zol (Invitrogen) according to manufacturer’si n s t r u c -
tions. Aliquots (5 μg) of DNase I-treated total RNA
were reverse transcribed using SuperScript
® III RNase
H-reverse transcriptase (Invitrogen). Total RNA from
human tissues was purchased from BD Clontech. Ali-
quots (1 μg) of total RNA from human tissues were
reverse transcribed using QuantiTect
® reverse transcrip-
tion kit (Qiagen).
Non quantitative PCR
PCR experiments were performed using Ampli Taq
Gold DNA Polymerase (Applied Biosystems), with buffer
recommended by the manufacturer, in a final reaction
volume of 10 μl. An Express (Thermo-Hybaid) thermal
cycler was used for the analysis of the 5’ half of SYBL1
gene, set as follows: 9’ at 96°C followed by 35 cycles
consisting of 30” melting at 95°C + 45” annealing at 58°
C+4 5 ” extension at 72°C; a final extension step at 72°C
was then performed for 5’. The forward (F) and reverse
(R) (MWG)-primer sequences were: SYN1F 5’-ATGGC-
GATTCTTTTTGCTGTTGTT-3’;S Y N 1 R5 ’-AGTG
CTGTCTGTGCTCTTGAACCGT-3’.T h e3 ’ architec-
ture of LD+ isoforms was investigated carrying out a
seminested PCR in the Robocycler (Stratagene) with an
annealing temperature of 55°C and steps of annealing
Vacca et al. BMC Molecular Biology 2011, 12:26
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Page 10 of 13and extension of 1’. In both PCRs the same forward pri-
mer, SYBL2/3F, was used: 5’-CGTACTCACATGG-
CAATTAT-3’. This forward primer (ASOa) is specific
to VAMP7a; it was combined to the TEL3 reverse pri-
mer: 5’-AGTCACATGGATTGCTTTTA-3’ in the first
PCR round (28 cycles) and to the TBP5: 5’-CAA-
GATTTCTGCTGGTAG-3’ in the second PCR round
(35 cycles) as nested reverse primer.
Real-time RT-PCR
All experiments were performed as follows: RNA for
each sample was extracted and reverse transcribed in
three replicates. In order to minimize variation depend-
ing on experimental error, real-time experiments were
then performed in five replicates for each sample, result-
ing in 3x5 = 15 replicates. Real-time PCR experiments
were performed using SYBR
®-Green core reagent kit
and Ampli Taq Gold DNA Polymerase (Applied Biosys-
tem) in a final reaction volume of 25 μl. The thermal
cycler (Rotor-Gene 3000 from Corbett Research) was set
as follows: 9’ at 95°C followed by 40 cycles consisting of
30” melting at 95°C + 30” annealing at 60°C + 35”
extension at 72°C. The gene encoding human ribosomal
protein S13 is the housekeeping control for normaliza-
tion [48]. For quantitative data analysis, the Rotor Gene
software (version 6.0.34) was used according to Pflaffl
[49] and Marino et al. [50]. The following F and R pri-
mers (SIGMA-Genosys) were used:
VAMP7a-F: 5’-CACTGATGATGATTTTGAACG-3’;
VAMP7a-R: 5’-CTGAGCTACCAGATCTATGTT
TCT-3’;
VAMP7b-R: 5’-TTGAAGGTGACAGACTATGTTTC-
3’;
VAMP7c-F: 5’-CTTCCTGGAGGATTTTGAAC-3’;
VAMP7d-F: 5’-CACATGGCAAGATTTTGAAC-3’;
VAMP7h-F: 5’-GGAAACTTCCTGGAGTTATTTG-3’;
VAMP7h-R: 5’-TCTCCATCACTTTGTCTAGGC-3’;
VAMP7i-F: 5’-GCAGATTCTGGCTAAGATACC-3’;
VAMP7i-R: 5’-TACCAGATCAGCTGTGCAG-3’;
VAMP7j-F: 5’-ACAGCTGTCTGTCACCTTC-3’;
VAMP7j-R: 5’-TCAGTATGTGAAAGGCTTGAG-3’;
S13-F: 5’-TACAAACTGGCCAAGAAGGG-3’;
S13-R: 5’-GGTGAATCCGGCTCTCTATTAG-3’.
Primers were designed and combined so that all ampli-
cons had (or almost) equal length (250 to 254 bps) hence
quantitative comparison could be extended to different
amplicons from all isoforms. Primer combinations to
amplify specific isoforms were: VAMP7a, VAMP7a-F +
VAMP7a-R; VAMP7b, VAMP7a-F + VAMP7b-R;
VAMP7c, VAMP7c-F + VAMP7a-R; VAMP7d, VAMP7d-
F + VAMP7a-R; VAMP7h, VAMP7h-F + VAMP7h-R;
VAMP7i, VAMP7i-F + VAMP7i-R; VAMP7j, VAMP7j-F +
VAMP7j-R.
Recombinant proteins
Plasmid pGEX expressing the cytoplasmic domain of
VAMP7a fused to the N-terminal GST tag was a kind
gift of Dr. Monica Cuccurese; the LD of VAMP7a/b (aa
1-118) and the novel C-terminal region of VAMP7b (aa
151-260) were cloned in a pET32(a) plasmid (Novagen)
and expressed in E. coli BL21 cells following standard
protocols.
Oligoclonal antibodies and immunoblotting
Whenever possible, peptide sequences were designed to
start N-terminally by a Cys residue (for conjugation to
the carrier protein) already present in the VAMP7 iso-
form sequences:
MD2 (CITDDDFERSRAFNFLNE; residues 64-81 of
VAMP7a and VAMP7b)
MD3 (Cys-RGERLELLIDKTENLVD; residues 150-166
of VAMP7a)
MD4 (CSSHVYEEPQAHYYH; residues 156-170 of
VAMP7b)
MD5 (CDSSLSHTDRWYLPV; residues 219-233 of
VAMP7b)
Peptide synthesis and conjugation, immunisation of
rabbits and sera collection were performed by a com-
pany (Sigma-Genosys); we then purified the antibodies
by affinity chromatography. Peptides were Cys-conju-
gated to the Sulfolink resin and chromatography was
performed using binding and elution buffers from
Pierce, following manufacturer’s instructions. After elu-
tion, antibodies were concentrated by ultrafiltration
using 10 kDa cut off filter tubes (Amicon). Strength and
specificity of each antibody was checked by dot-blot
analysis, using as targets progressive dilutions of (i) each
specific peptide, (ii) the other three VAMP7 peptides
and (iii) peptides from non-homologous proteins. For
immunoblotting, protein samples were separated by
standard SDS-PAGE and blotted onto nitrocellulose fil-
ters using Protean and Transblot cells (Bio-Rad). Pri-
mary antibodies were diluted 1:1000; secondary antibody
(anti rabbit IgG-HRP, Santa Cruz Biotechnology) was
diluted 1:20000. Enhanced chemiluminescence detection
was performed using the Supersignal system (Pierce),
following manufacturer’s instructions; blot images were
acquired using a Chemi-Doc image analysis system (Bio-
Rad).
Subcellular localization experiments
The main isoform and splice variants of VAMP7 were
tagged with a fluorescent protein (either red, RFP, or
green, EGFP) cloning the isoform cds in pRFP-C3,
pEGFP-C3 or pEGFP-N1 (Invitrogen). VAMP7b has C-
terminal tag, whereas VAMP7d/h, VAMP7i and
VAMP7j have N-terminal tags.
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Page 11 of 13HeLa cells were transiently cotransfected using Lipo-
fectamine™2000 protocol (Invitrogen) with pRFP-C3-
VAMP7a and pEGFP-N1-VAMP7b or pEGFP-C3-
VAMP7dh, pEGFP-C3-VAMP7i, pEGFP-C3-VAMP7j.
Then, in vivo analysis was performed at 15/22/24/48h
by using a TCS SP2 confocal scanning microscope
(Leica, Heidelberg, Germany), sequential excitation with
488 nm, 543 nm laser beams, 63X 1.4 NA lens (low
magnification: zoom 2-3; high magnification: zoom 5-8)
and LAS AF Software. Images (size set to 512x512 pix-
els) were assembled by using ImageJ.
Bioinformatics
Melting temperatures of PCR primers were calculated
using DNA Calculator http://www.sigma-genosys.com/
calc/DNACalc.asp; possible occurrence of hairpins, self-
and hetero-dimers was ruled out by Oligo analyzer 3.1
http://eu.idtdna.com/analyzer/applications/oligoanalyzer/
default.aspx and the specificity was checked with MFE-
primer http://biocompute.bmi.ac.cn/MFEprimer/[51],
scanning both genomic and transcriptomic human data-
bases. Translation Initiation Site (TIS) prediction was
performed using StartScan http://bioinformatics.psb.
ugent.be/webtools/startscan/[42]; in silico translation of
coding sequences resulting from likely alternative start
codons was obtained using the Traslate tool at the
ExPAsy server http://www.expasy.ch/tools/dna.html.
Antigenic regions of VAMP7 isoforms were predicted
based on the antigenic index plot obtained using the
Protean module of the Lasergene Package (DNASTAR);
selection of peptide sequences was based on both their
conservation/specifity and predicted solubility.
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